Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HIRSH

Showing results (311-320 of 666) with videos related to

Pageof 67
Sort By:
Blood|March 1, 1973
Relation between bleeding time and platelet connective tissue reaction after aspirinJ Hirsh, D Street, J F Cade, et al.
British Journal of Haematology|August 1, 1970
Platelet glycolytic enzymes: effect of cellular disruption procedures on activityJ C Doery, J Hirsh, G C De Gruchy
Thrombosis and Haemostasis|June 1, 1992
Heparin binding to plasma proteins, an important mechanism for heparin resistanceE Young, M Prins, M N Levine, et al.
The New England Journal of Medicine|December 4, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts)E Genton, M Gent, J Hirsh, et al.
Blood|October 1, 1980
Immunodepletion of human plasma factor VIIIF Ofosu, K Cassidy, M A Blajchman, et al.
European Heart Journal|July 1, 1995
Advances in antithrombotic drug therapy for coronary artery diseaseC S Rihal, M Flather, J Hirsh, et al.
Blood|January 1, 1985
The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparinM R Buchanan, B Boneu, F Ofosu, et al.
The Journal of Clinical Investigation|April 1, 1993
Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysisJ I Weitz, B Leslie, J Hirsh, et al.
The Medical Journal of Australia|January 3, 1970
Evaluation of subcutaneous calcium heparin therapy in the treatment of thrombo-embolic diseaseJ Hirsh, E F O'Sullivan, A S Gallus, et al.
The American Journal of Physiology|November 1, 1996
Effect of cholecystokinin and related peptides on jejunal transepithelial hexose transport in the Sprague-Dawley ratA J Hirsh, R Tsang, S Kammila, et al.
Pageof 67

Showing results (311-320 of 666) with videos related to

Sort By:
Pageof 67
Blood|March 1, 1973
Relation between bleeding time and platelet connective tissue reaction after aspirinJ Hirsh, D Street, J F Cade, et al.
British Journal of Haematology|August 1, 1970
Platelet glycolytic enzymes: effect of cellular disruption procedures on activityJ C Doery, J Hirsh, G C De Gruchy
Thrombosis and Haemostasis|June 1, 1992
Heparin binding to plasma proteins, an important mechanism for heparin resistanceE Young, M Prins, M N Levine, et al.
The New England Journal of Medicine|December 4, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts)E Genton, M Gent, J Hirsh, et al.
Blood|October 1, 1980
Immunodepletion of human plasma factor VIIIF Ofosu, K Cassidy, M A Blajchman, et al.
European Heart Journal|July 1, 1995
Advances in antithrombotic drug therapy for coronary artery diseaseC S Rihal, M Flather, J Hirsh, et al.
Blood|January 1, 1985
The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparinM R Buchanan, B Boneu, F Ofosu, et al.
The Journal of Clinical Investigation|April 1, 1993
Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysisJ I Weitz, B Leslie, J Hirsh, et al.
The Medical Journal of Australia|January 3, 1970
Evaluation of subcutaneous calcium heparin therapy in the treatment of thrombo-embolic diseaseJ Hirsh, E F O'Sullivan, A S Gallus, et al.
The American Journal of Physiology|November 1, 1996
Effect of cholecystokinin and related peptides on jejunal transepithelial hexose transport in the Sprague-Dawley ratA J Hirsh, R Tsang, S Kammila, et al.
Pageof 67